X-Energy (XE) Q2 2026 Earnings Call Transcript

X-Energy reported Q2 2026 total revenues and grant income of $54.6M (+154% YoY), driven by ARDP engineering activity ($50.1M services revenue; $4.5M grant income) and $547M in DOE reimbursements received by June 30. Liquidity rose to $1.9B after a $1.1B IPO, while cash used in operating activities was $97.3M and TX-1 fuel facility vertical construction was ~80% complete (on track for the next 3Q milestone). The company also announced an additional up to $1B DOE allocation to the ARDP (total potential DOE cost share up to ~$2.115B) and secured long-term HALEU enrichment agreements (plus $10M private capital commitment to DOE Project Prometheus), alongside $148M TRISO-X federal tax credits and a planned imminent 1GW utility project announcement.

Analysis

This is more a supply-chain de-risking event than a true step-change in economics. The incremental winner is not the reactor developer alone; it is the small set of bottleneck suppliers that can monetize scarcity before end customers can source directly, especially HALEU enrichment and nuclear-grade graphite. That makes LEU/centrus-adjacent exposure and specialty materials like SGLFF more interesting than a straight chase in XE, because those businesses can capture the “picks-and-shovels” premium without carrying single-project execution risk.

For XE, the near-term upside is sentiment and backlog quality, not current cash earnings. The market should keep focusing on the sequence of catalysts: TX-1 milestones in the next quarter, NRC timing into late 2026/early 2027, and the rumored utility contract in the next 1-3 months. If any of those slip, the valuation likely compresses quickly because the company is still pre-commercial, highly policy-dependent, and carrying a very large diluted share count relative to current operating income.

The consensus may be overestimating how much of this progress converts to shareholder economics versus how much simply transfers risk to suppliers and future customers. The bull case is real, but the stock remains a financing-and-timeline story with meaningful dilution risk if buildout accelerates faster than customer-funded transfer mechanics. A cleaner expression is to own the bottleneck inputs and stay patient on XE until there is a signed utility project and a firmer line of sight on licensing completion.

Key Decisions for Investors

• Long LEU / short XE for 1-3 months: captures HALEU bottleneck monetization while hedging against XE’s schedule, dilution, and policy risk; thesis breaks if XE converts the rumored utility deal into a binding FID and NRC timing tightens materially.
• Buy SGLFF on weakness for 6-12 months as a smaller picks-and-shovels beneficiary of advanced nuclear scale-up; risk/reward is attractive if graphite capacity expansion turns into recurring reactor-related demand, but liquidity and contract size are the main constraints.
• Avoid chasing XE common after the headline; wait for a pullback or use defined-risk call structures only after the utility announcement is confirmed, since the current move is driven more by narrative de-risking than by near-term earnings power.
• Set a watch item on XE for the late-2026 NRC review and the next customer announcement: if either slips by more than one quarter, expect multiple compression and use that as an opportunity to fade the enthusiasm.